olmesartan has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Busby, J; Cardwell, CR; Hughes, C; Johnston, BT; McMenamin, Ú; Spence, A | 1 |
| Carl-McGrath, S; Ebert, MP; Lendeckel, U; Röcken, C | 1 |
2 other study(ies) available for olmesartan and Stomach Neoplasms
| Article | Year |
|---|---|
Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Benzimidazoles; Biphenyl Compounds; Child; Child, Preschool; Cohort Studies; Diabetic Neuropathies; Esophageal Neoplasms; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Imidazoles; Infant; Infant, Newborn; Losartan; Male; Middle Aged; Registries; Stomach Neoplasms; Survival Analysis; Tetrazoles; Young Adult | 2018 |
Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 2 Receptor Blockers; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Enalapril; Female; Gene Expression Regulation, Neoplastic; Genotype; Humans; Imidazoles; Immunohistochemistry; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Peptidyl-Dipeptidase A; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; Stomach Neoplasms; Tetrazoles | 2007 |